J. Lacey, J. Hewitt, J. L. Daley-Morris, J. James, J. Stevens, and O. Blaizel, “Expert clinical framework report: Management of adverse events related to novel therapies for relapsed/refractory multiple myeloma (RRMM)”, Can Hematol Today, vol. 1, no. S11, Nov. 2022.